Search Results - "Kortman, Pim"

  • Showing 1 - 13 results of 13
Refine Results
  1. 1

    In-depth analysis of immunohistochemistry concordance in biopsy-resection pairs of bronchial carcinoids by Naves, Dwayne D, Reuling, Ellen M B P, Dickhoff, Chris, Kortman, Pim C, Broeckaert, Mark A M, Plaisier, Peter W, Daniels, Johannes M A, Thunnissen, Erik, Radonic, Teodora

    Published in Annals of diagnostic pathology (01-12-2023)
    “…Primary diagnosis of bronchial carcinoids (BC) is always made on biopsies and additional immunohistochemistry (IHC) is often necessary. In the present study we…”
    Get full text
    Journal Article
  2. 2

    Diagnosis of atypical carcinoid can be made on biopsies > 4 mm2 and is accurate by Reuling, Ellen M. B. P., Naves, Dwayne D., Daniels, Johannes M. A., Dickhoff, Chris, Kortman, Pim C., Broeckaert, Mark A. M. B., Plaisier, Peter W., Thunnissen, Erik, Radonic, Teodora

    “…In the 2021 WHO thoracic tumors, gradation of lung carcinoids in biopsies is discouraged. We hypothesized that atypical carcinoid (AC) could be reliably…”
    Get full text
    Journal Article
  3. 3
  4. 4

    A Multimodal Biomarker Predicts Dissemination of Bronchial Carcinoid by Reuling, Ellen M B P, Naves, Dwayne D, Kortman, Pim C, Broeckaert, Mark A M, Plaisier, Peter W, Dickhoff, Chris, Daniels, Johannes M A, Radonic, Teodora

    Published in Cancers (30-06-2022)
    “…Background: Curatively treated bronchial carcinoid tumors have a relatively low metastatic potential. Gradation into typical (TC) and atypical carcinoid (AC)…”
    Get full text
    Journal Article
  5. 5

    Abrogation of BRAFV600E-induced senescence by PI3K pathway activation contributes to melanomagenesis by Vredeveld, Liesbeth C W, Possik, Patricia A, Smit, Marjon A, Meissl, Katrin, Michaloglou, Chrysiis, Horlings, Hugo M, Ajouaou, Abderrahim, Kortman, Pim C, Dankort, David, McMahon, Martin, Mooi, Wolter J, Peeper, Daniel S

    Published in Genes & development (15-05-2012)
    “…Human melanocytic nevi (moles) are benign lesions harboring activated oncogenes, including BRAF. Although this oncogene initially acts mitogenically,…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    Diagnosis of atypical carcinoid can be made on biopsies > 4 mm 2 and is accurate by Reuling, Ellen M B P, Naves, Dwayne D, Daniels, Johannes M A, Dickhoff, Chris, Kortman, Pim C, Broeckaert, Mark A M B, Plaisier, Peter W, Thunnissen, Erik, Radonic, Teodora

    “…In the 2021 WHO thoracic tumors, gradation of lung carcinoids in biopsies is discouraged. We hypothesized that atypical carcinoid (AC) could be reliably…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Abrogation of BRAF V600E -induced senescence by PI3K pathway activation contributes to melanomagenesis by Vredeveld, Liesbeth C.W., Possik, Patricia A., Smit, Marjon A., Meissl, Katrin, Michaloglou, Chrysiis, Horlings, Hugo M., Ajouaou, Abderrahim, Kortman, Pim C., Dankort, David, McMahon, Martin, Mooi, Wolter J., Peeper, Daniel S.

    Published in Genes & development (15-05-2012)
    “…Human melanocytic nevi (moles) are benign lesions harboring activated oncogenes, including BRAF . Although this oncogene initially acts mitogenically,…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Small-Molecule XIAP Antagonist Restores Caspase-9-Mediated Apoptosis in XIAP-Positive Diffuse Large B-Cell Lymphoma Cells by Cillessen, Saskia A.G.M., Reed, John C., Pinilla, Clemencia, Meijer, Chris J.L.M., Hooijberg, Erik, Hess, Corine J., Castricum, Kitty C.M., Kortman, Pim, Ossenkoppele, Gert J., Oudejans, Joost J.

    Published in Blood (16-11-2007)
    “…Clinical outcome in patients with diffuse large B-cell lymphomas (DLBCL) is correlated with expression of inhibitors of the intrinsic apoptosis pathway,…”
    Get full text
    Journal Article
  13. 13

    Chemotherapy-Refractory Diffuse Large B-Cell Lymphomas (DLBCL) Are Effectively Killed by Ofatumumab-Induced Complement-Mediated Cytoxicity by Cillessen, Saskia A.G.M., Mackus, Wendy J.M., Castricum, Kitty C.M., Vos, Wim, Kortman, Pim C., van de Winkel, Jan G.J., Parren, Paul W.H.I., Meijer, Chris J.L.M., Oudejans, Joost J., (Intr. by Ole Baadsgaard)

    Published in Blood (16-11-2007)
    “…The combination of chimeric CD20 monoclonal antibody (mAb) rituximab (R) with chemotherapy (CHOP) has significantly improved clinical outcome in patients with…”
    Get full text
    Journal Article